These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10833839)

  • 1. [The effect of Clexane (low-molecular-weight heparin) on the hemostatic system and on the incidence of postoperative thrombotic complications in gynecological cancer patients].
    Madzhuga AV; Somonova OV; Kononenko LP; Gorobets ES; Elizarova AL; Astakhova VM
    Anesteziol Reanimatol; 2000; (2):54-6. PubMed ID: 10833839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-molecular-weight heparin - enoxaparin (clexane) in the prevention of thromboembolic complications in surgical patients].
    Zabolotskikh IB; Sin'kov SV; Klevko VA
    Anesteziol Reanimatol; 2001; (2):70-5. PubMed ID: 11494909
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complex prevention of thrombotic complications in patients with colorectal cancer during different stages of surgical treatment].
    Mal'kov OA; Dolgikh VT; Lukach VN
    Anesteziol Reanimatol; 2001; (5):52-4. PubMed ID: 11757303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A trial of the use of low-molecular-weight heparin (fraksiparin) in myocardial infarct].
    Savenkov MP; Borshchevskaia MV; Gvozdkov AL; Semenova EN
    Ter Arkh; 1996; 68(8):8-12. PubMed ID: 9019842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
    Heidenreich C; Hohmann V; Bramlage P
    Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative evaluation of enoxaparin and non-fractionated heparin in patients with pancreonecrosis].
    Zabolotskikh IB; Sin'kov SV; Golubtsov VV; Zalesnyĭ SA; Klevko VA
    Anesteziol Reanimatol; 2002; (2):70-2. PubMed ID: 12227006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative anticoagulation in vascular surgery: part 1. A retrospective comparison of clinical outcomes for unfractionated heparin versus low-molecular-weight heparin.
    Gramse CA; Hingorani A; Ascher E
    J Vasc Nurs; 2001 Jun; 19(2):42-9; quiz 50-1. PubMed ID: 11395717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clexane (enoxaprin) or Fragmin (dalteparin) for thrombolytic prevention in hip replacement surgery?].
    Gjengedal E; Uppheim G
    Tidsskr Nor Laegeforen; 1996 Jun; 116(15):1782-4. PubMed ID: 8693460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods of heparin therapy in surgical patients with thrombohemorrhagic syndrome].
    Gasanov FD
    Anesteziol Reanimatol; 2012; (2):61-4. PubMed ID: 22834292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative use of enoxaparin compared with unfractionated heparin increases the incidence of re-exploration for postoperative bleeding after open-heart surgery in patients who present with an acute coronary syndrome: clinical investigation and reports.
    Jones HU; Muhlestein JB; Jones KW; Bair TL; Lavasani F; Sohrevardi M; Horne BD; Doty D; Lappe DL
    Circulation; 2002 Sep; 106(12 Suppl 1):I19-22. PubMed ID: 12354703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Deep veins thrombosis prophylaxis in patients with fractures of long bones of the lower limbs].
    Reshetnikov EA; Gorodnichenko AI; Boriskin AA
    Khirurgiia (Mosk); 2009; (8):15-20. PubMed ID: 19738556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study on the use of a low-molecular-weight heparin for thromboembolism prophylaxis in large-volume liposuction and body contouring procedures.
    Newall G; Ruiz-Razura A; Mentz HA; Patronella CK; Ibarra FR; Zarak A
    Aesthetic Plast Surg; 2006; 30(1):86-95; discussion 96-7. PubMed ID: 16404651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
    Franke J; Schaeper O; Kayser R; Mahlfeld K
    Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of hemostatic disorders at different stages of surgical treatment in patients with colonic cancer].
    Elizarova AL; Madzhuga AV; Somonova OV; Larionova VB; Gorobets ES; Anan'ev VS
    Anesteziol Reanimatol; 1994; (6):39-42. PubMed ID: 7733478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of enoxaparin versus unfractionated heparin in general surgery. SURGEX-Study Group.
    Verhaeghe R
    Eur J Surg Suppl; 1994; (571):35. PubMed ID: 7519087
    [No Abstract]   [Full Text] [Related]  

  • 17. [Low molecular-weight heparin (clexane) in the prevention of thrombotic events in patients with malignancies].
    Somonova OV; Madzhuga AV; Elizarova AL; Sel'chuk VIu; Zubrikhina GN; Bokhian AIu
    Klin Lab Diagn; 2006 Aug; (8):31-3. PubMed ID: 17087245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Heparin prophylaxis of thrombohemorrhagic complications in surgical interventions in cancer patients].
    Nadiradze ISh
    Vopr Onkol; 1989; 35(8):974-9. PubMed ID: 2800447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysis.
    Sarasin FP; Bounameaux H
    Thromb Haemost; 2002 Apr; 87(4):586-92. PubMed ID: 12008939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.